Intelligence · Clinical Pipeline

First Biotech (Australia) Pipeline

All ClinicalTrials.gov programs at First Biotech (Australia) — phase, modality, and trial IDs.

Programs: 126

Quick answer

First Biotech (Australia) has 126 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin® (somatropin) Delivery and Taken Up Into the Blood in Healthy Adults

Pfizer Australia Pty Ltd

Growth hormone deficiency

phase 1 other active

1 trial
A Study to Learn How a Tablet Compared with an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up into the Blood in Healthy Adults.

Pfizer Australia Pty Ltd

ER+/HER2- breast cancer

phase 1 other active

1 trial
A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up into the Blood of Healthy Adults After Taking Different Tablets of the Study Medicine Called Ibuzatrelvir.

Pfizer Australia Pty Ltd

Coronavirus disease 2019

phase 1 other active

1 trial
A Study to Learn If The Study Medicine Called Fluconazole Changes How the Body Processes The Other Study Medicine PF-07248144

Pfizer Australia Pty Ltd

locally advanced or metastatic HR+/HER2- breast cancer

phase 1 other active

1 trial
A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam

Pfizer Australia Pty Ltd

ER+/HER2 positive breast cancer

phase 1 other active

1 trial
A Study to Learn how Various Tablets of the Study Medicine Called Vepdegestrant are Taken up into the Blood in Healthy Adults

Pfizer Australia Pty Ltd

ER+/HER2- Breast Cancer

phase 1 other active

1 trial
A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144

Pfizer Australia Pty Ltd

locally advanced or metastatic ER+/HER2- breast cancer

phase 1 other active

1 trial
A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults

Pfizer Australia Pty Ltd

Type 2 Diabetes Mellitus, Obesity, Overweight management

phase 1 other active

1 trial
A Study to Understand What the Body Does to the Study Medicine Called PF-07976016 When Taken by Healthy Adults

Pfizer Australia Pty Ltd

Obesity, Overweight

phase 1 other active

1 trial
A study to Learn If Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults.

Pfizer Australia Pty Ltd

Heart Failure

phase 1 other active

1 trial
A study to establish the bioequivalence of free acid tafamidis 61 mg capsule and tablet, and evaluate the safety and tolerability of the 61 mg tablet in healthy adults

Pfizer Australia Pty Ltd

Transthyretin amyloidosis

phase 1 other active

1 trial
A study to learn about the study medicine called PF-08046032 in people with advanced cancers.

Pfizer Australia Pty Ltd

Advanced lymphomas (classic Hodgkin lymphoma [cHL], peripheral T cell lymphoma [PTCL], and diffuse large B cell lymphoma [DLBCL]), Solid tumors (eg, NSCLC, HNSCC, and melanoma)

phase 1 other active

1 trial
A study to learn how different amounts of the study medicine called PF-07941944 are tolerated in the body of healthy adults.

Pfizer Australia Pty Ltd

RSV (Respiratory Syncytial Virus)

phase 1 other active

1 trial
A study to learn how the study medicine called [14C]PF-07054894 is processed by the body.

Pfizer Australia Pty Ltd

Inflammatory bowel disease.

phase 1 other active

1 trial
ADME: A Study to Understand What the Body does to the Study Compound Called PF-07220060 When Taken by Healthy Adults.

Pfizer Australia Pty Ltd

metastatic/advanced breast cancer

phase 1 other active

1 trial
C5951001- A Phase 1 Study of PF-08046876 in Participants with Advanced Solid Tumors.

Pfizer Australia Pty Ltd

advanced solid tumors

phase 1 other active

1 trial
C6001001 - A Study to Learn about the Study Medicine PF-08052667 in People with Bladder Cancer.

Pfizer Australia Pty Ltd

Non-muscle invasive bladder cancer (NMIBC)

phase 1 other active

1 trial
C6081001: A Phase 1 Study of PF-07985045 in Participants with Advanced Solid Tumors

Pfizer Australia Pty Ltd

KRAS mutated advanced solid tumors

phase 1 other active

1 trial
Etrasimod Arginine Blue

Pfizer Australia Pty Ltd

Ulcerative Colitis and immune-mediated inflammatory disorders

phase 1 small molecule active

1 trial
Mevrometostat Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

Pfizer Australia Pty Ltd

Castration Resistant Prostate Cancer (CRPC), Follicular Lymphoma (FL), Small Cell Lung Cancer (SCLC), Diffuse Large B-Cell Lymphoma (DLBCL)

phase 1 other active

1 trial
PF-07868489 Placebo, PF-07868489

Pfizer Australia Pty Ltd

Pulmonary Arterial Hypertension

phase 1 small molecule active

1 trial
Single Dose Pharmacokinetics and Relative Bioavailability of Sayana Press via Upper Arm Injection Relative to Anterior Thigh and Abdomen

Pfizer Australia Pty Ltd

long-term female contraception

phase 1 other active

1 trial
Tafamidis round 2, Tafamidis round 1, Tafamidis oblong

Pfizer Australia Pty Ltd

aransthyretin amyloid cardiomyopathy

phase 1 small molecule active

1 trial
Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant)

Pfizer Australia Pty Ltd

RSV-infection

approved small molecule active

1 trial
Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar suspension for injection in pre-filled syringe Pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed), Apexxnar sus

Pfizer Australia Pty Ltd

VACCINE-TYPE RADIOLOGICALLY-CONFIRMED COMMUNITY-ACQUIRED PNEUMONIA

approved small molecule active

1 trial
Braftovi 50 mg hard capsules, Zelboraf 240 mg film-coated tablets, Encorafenib, Erbitux 5 mg/mL solution for infusion, PEMBROLIZUMAB, Braftovi 75 mg hard capsules, Braftovi 75 mg hard capsules, Braftovi 50 mg hard capsules, Ribociclib, Ribociclib, NIVOLUMAB, Mektovi 15 mg film-coated tablets, Mektovi 15 mg film-coated tablets, Ribociclib

Pfizer Australia Pty Ltd

Solid tumors

approved small molecule active

1 trial
LORLATINIB

Pfizer Australia Pty Ltd

Lung cancer

approved small molecule active

1 trial
Placebo for Rimegepant 75 mg, VYDURA 75 mg oral lyophilisate

Pfizer Australia Pty Ltd

migraine headaches with or without aura

approved small molecule active

1 trial
VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg

Pfizer Australia Pty Ltd

Migraine attacks with or without aura

approved small molecule active

1 trial
XALKORI 200 mg hard capsules, XALKORI 250 mg hard capsules, Crizotinib 200 mg capsules, Crizotinib 250 mg capsules

Pfizer Australia Pty Ltd

This Master Protocol for Crizotinib Continuation Sub-Studies has been designed to provide continued treatment access for eligible participants who continue to derive clinical benefit from study intervention in a Pfizer sponsored crizotinib parent study that will be closed

approved small molecule active

1 trial

Frequently asked questions

How many pipeline programs does First Biotech (Australia) have?

126 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Quick answer

A Study to Learn How Different Injector Pens Affect the Study Medicine Called Genotropin® (somatropin) Delivery and Taken Up Into the Blood in Healthy Adults

A Study to Learn How a Tablet Compared with an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up into the Blood in Healthy Adults.

A Study to Learn How the Study Medicine Called Ibuzatrelvir is Taken up into the Blood of Healthy Adults After Taking Different Tablets of the Study Medicine Called Ibuzatrelvir.

A Study to Learn If The Study Medicine Called Fluconazole Changes How the Body Processes The Other Study Medicine PF-07248144

A Study to Learn If the Study Medicine Called Vepdegestrant Changes How the Body Processes the Other Study Medicine Called Midazolam

A Study to Learn how Various Tablets of the Study Medicine Called Vepdegestrant are Taken up into the Blood in Healthy Adults

A Study to Learn if Multiple Doses of the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine PF-07248144

A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults

A Study to Understand What the Body Does to the Study Medicine Called PF-07976016 When Taken by Healthy Adults

A study to Learn If Study Medicines Called Cyclosporine and Clarithromycin Affect How the Body Processes the Other Study Medicine Called PF-07328948 in Healthy Adults.

A study to establish the bioequivalence of free acid tafamidis 61 mg capsule and tablet, and evaluate the safety and tolerability of the 61 mg tablet in healthy adults

A study to learn about the study medicine called PF-08046032 in people with advanced cancers.

A study to learn how different amounts of the study medicine called PF-07941944 are tolerated in the body of healthy adults.

A study to learn how the study medicine called [14C]PF-07054894 is processed by the body.

ADME: A Study to Understand What the Body does to the Study Compound Called PF-07220060 When Taken by Healthy Adults.

C5951001- A Phase 1 Study of PF-08046876 in Participants with Advanced Solid Tumors.

C6001001 - A Study to Learn about the Study Medicine PF-08052667 in People with Bladder Cancer.

C6081001: A Phase 1 Study of PF-07985045 in Participants with Advanced Solid Tumors

Etrasimod Arginine Blue

Mevrometostat Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

PF-07868489 Placebo, PF-07868489

Single Dose Pharmacokinetics and Relative Bioavailability of Sayana Press via Upper Arm Injection Relative to Anterior Thigh and Abdomen

Tafamidis round 2, Tafamidis round 1, Tafamidis oblong

Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant)

LORLATINIB

Placebo for Rimegepant 75 mg, VYDURA 75 mg oral lyophilisate

VYDURA 75 mg oral lyophilisate, Placebo for Rimegepant 75 mg

XALKORI 200 mg hard capsules, XALKORI 250 mg hard capsules, Crizotinib 200 mg capsules, Crizotinib 250 mg capsules

Frequently asked questions

Stay Ahead in Pharma